We are upgrading the repository! A content freeze is in effect until December 11, 2024. New submissions or changes to existing items will not be allowed during this period. All content already published will remain publicly available for searching and downloading. Updates will be posted in the Website Upgrade 2024 FAQ in the sidebar Help menu. Reach out to escholarship@umassmed.edu with any questions.

Show simple item record

dc.contributor.authorRaptis, Constantine A
dc.contributor.authorGoldstein, Alan
dc.contributor.authorHenry, Travis S
dc.contributor.authorPorter, Kristin K
dc.contributor.authorCatenacci, Daniel
dc.contributor.authorKelly, Aine Marie
dc.contributor.authorKuzniewski, Christopher T
dc.contributor.authorLai, Andrew R
dc.contributor.authorLee, Elizabeth
dc.contributor.authorLong, Jason M
dc.contributor.authorMartin, Maria D
dc.contributor.authorMorris, Michael F
dc.contributor.authorSandler, Kim L
dc.contributor.authorSirajuddin, Arlene
dc.contributor.authorSurasi, Devaki Shilpa
dc.contributor.authorWallace, Graham W
dc.contributor.authorKamel, Ihab R
dc.contributor.authorDonnelly, Edwin F
dc.date.accessioned2022-12-08T20:23:24Z
dc.date.available2022-12-08T20:23:24Z
dc.date.issued2022-11-01
dc.identifier.citationExpert Panels on Thoracic and Gastrointestinal Imaging, Raptis CA, Goldstein A, Henry TS, Porter KK, Catenacci D, Kelly AM, Kuzniewski CT, Lai AR, Lee E, Long JM, Martin MD, Morris MF, Sandler KL, Sirajuddin A, Surasi DS, Wallace GW, Kamel IR, Donnelly EF. ACR Appropriateness Criteria® Staging and Follow-Up of Esophageal Cancer. J Am Coll Radiol. 2022 Nov;19(11S):S462-S472. doi: 10.1016/j.jacr.2022.09.008. PMID: 36436970.en_US
dc.identifier.eissn1558-349X
dc.identifier.doi10.1016/j.jacr.2022.09.008en_US
dc.identifier.pmid36436970
dc.identifier.urihttp://hdl.handle.net/20.500.14038/51417
dc.description.abstractThis document provides recommendations regarding the role of imaging in the staging and follow-up of esophageal cancer. For initial clinical staging, locoregional extent and nodal disease are typically assessed with esophagogastroduodenoscopy and esophageal ultrasound. FDG-PET/CT or CT of the chest and abdomen is usually appropriate for use in initial clinical staging as they provide additional information regarding distant nodal and metastatic disease. The detection of metastatic disease is critical in the initial evaluation of patients with esophageal cancer because it will direct patients to a treatment pathway centered on palliative radiation rather than surgery. For imaging during treatment, particularly neoadjuvant chemotherapy, FDG-PET/CT is usually appropriate, because some studies have found that it can provide information regarding primary lesion response, but more importantly it can be used to detect metastases that have developed since the induction of treatment. For patients who have completed treatment, FDG-PET/CT or CT of the chest and abdomen is usually appropriate for evaluating the presence and extent of metastases in patients with no suspected or known recurrence and in those with a suspected or known recurrence. The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.en_US
dc.language.isoenen_US
dc.relation.ispartofJournal of the American College of Radiologyen_US
dc.relation.urlhttps://doi.org/10.1016/j.jacr.2022.09.008en_US
dc.rightsCopyright © 2022 American College of Radiology. Published by Elsevier Inc. All rights reserved.en_US
dc.subjectAUCen_US
dc.subjectAppropriate Use Criteriaen_US
dc.subjectAppropriateness Criteriaen_US
dc.subjectCTen_US
dc.subjectEsophageal canceren_US
dc.subjectFDG-PET/CTen_US
dc.subjectFDG-PET/MRIen_US
dc.subjectMRIen_US
dc.subjectNeoadjuvant chemotherapyen_US
dc.titleACR Appropriateness Criteria® Staging and Follow-Up of Esophageal Canceren_US
dc.typeJournal Articleen_US
dc.source.journaltitleJournal of the American College of Radiology : JACR
dc.source.volume19
dc.source.issue11S
dc.source.beginpageS462
dc.source.endpageS472
dc.source.countryUnited States
dc.identifier.journalJournal of the American College of Radiology : JACR
dc.contributor.departmentRadiologyen_US


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record